CDT

Conduit Pharmaceuticals Inc.

NASDAQ: CDT · HEALTHCARE · BIOTECHNOLOGY

$0.25

-27.49% today

Updated 2026-09-11

Market cap

$3.42M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3,050.69

Dividend yield

—

52W range

$0 – $236

Volume

1.4M

Market cap

$3.42M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3,050.69

Dividend yield

—

52W range

$0 – $236

Volume

1.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.5

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

1.8

Altman Z-Score

Grey zone

—

Industry rank

—

View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Free cash flow $2.08M — positive

Risks

- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$922.22M	$2.72B	$750.16M
Net income	$-4.89M	$-535000.00	$-17.80M	$-39.22M	$68.54M
EPS	—	—	—	—	$-3,050.69
Free cash flow	$-2.27M	$-7.72M	$-9.73M	$-17.96M	$2.08M
Profit margin	—	—	-1.93%	-1.44%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CDT	$3.42M	26	4.3	3.5	5.0	6.5	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	2.7	6.0	-88.93%	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-69.36%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-73.74%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	6.0	-16.10%	Buy

Smart narrative

Conduit Pharmaceuticals Inc. trades at $0.25. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 1.84, it sits in the grey zone.

Frequently asked questions

What is Conduit Pharmaceuticals Inc.'s stock price?

Conduit Pharmaceuticals Inc. (CDT) trades at $0.25.

Is Conduit Pharmaceuticals Inc. overvalued?

Conduit Pharmaceuticals Inc. carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Conduit Pharmaceuticals Inc.'s Altman Z-Score is 1.84, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.conduitpharma.com

Quick metrics

P/S ratio—

ROE1.29%

Beta1.45

50D MA$2.75

200D MA$133.47

Shares out0.01B

Float0.00B

Short ratio—

Avg volume1.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CDT vs LLY →CDT vs JNJ →CDT vs ABBV →Stock screener →